Top Third in the Country

The Internal Medicine Research Program is in the top third of the country with numerous recent multi-year awards keeping the program vibrant. We have over $44 million in awards, including 70 NIH proposals and competitive renewals, 68 other proposals and competitive renewals, 82 NIH awards, and 162 other awards.

Our faculty and researchers have many resources available to help with their research, including, but not limited to, the following:

  • A full range of advanced technology and expertise available through the HSC Core Research Facilities. 
  • The Technology Venture (TV) Office, which provides funds to current entrepreneurial faculty/researchers and to hire new world-class scientists.  This office helped the University of Utah overtake MIT to become America's No. 1 research institution for creating startup companies based on university technology. Faculty recently spotlighted by TV include:
    • Hematologist Paul Shami with his innovative nitric oxide cancer studies
    • Gastroenterologist John Fang, who worked with student engineering teams to develop safer optic guided feeding tubes
  • Strong collaboration with other departments, with numerous opportunities to share knowledge through joint labs and conferences such as:
    • Internal Medicine Conferences,
    • Molecular Biology Conferences,
    • Human Genetics Seminars, and
    • HCI Research Seminars.
  • Access to the Utah Population Database, one of the world's richest sources of in-depth information to supports research on genetics, epidemiology, and public health.  

Major Research Areas

  • Blood and bone marrow disorders and malignancies
  • Cancer-causing viruses
  • Chronic obstructive pulmonary disease (COPD) Cystic fibrosis
  • Diabetes, endocrinology, and metabolism disorders
  • Epidemiology tools to detect and respond to known and emerging disease threats
  • Familial gene studies related to malignant and benign disorders
  • Genetics and nicotine addiction
  • Glucosamine and chondroitin sulfate in knee osteoarthritis
  • Hexosamine glucose toxicity
  • HIV and other infectious diseases
  • Kidney diseases
  • Liver disease, GI, and esophageal disorders and malignancies Nitric oxide as a cancer treatment
  • Oxidation risk factors
  • Prostate, lung, colorectal, and ovarian cancer screening Reductive stress and heart disease
  • Rural program in antimicrobials in the Intermountain region
  • Stem cell therapy
  • Systolic blood pressure intervention trials (SPRINT)
  • Vascular and skeletal muscle functions in aging humans
  • Vasculitis and scleroderma studies